DAVASAICIN HYDROCHLORIDE
UNII 51V6N8BA2P

Substance Identification & Data

This profile provides standardized clinical and technical data for Davasaicin Hydrochloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 51V6N8BA2P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 174661-97-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

51V6N8BA2P

CAS Registry Number

174661-97-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DAVASAICIN HYDROCHLORIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C22H30N2O3.ClH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

OUEKLNJUMVZULZ-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C216515

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

177286

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(cc(c(cc1)OCCN)OC)CC(=O)NCCCc2cc(c(cc2)C)C.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Davasaicin Hydrochloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.